RPRX vs PFGC Comparison

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Performance Food Group Co is the third-largest U.S. food-service distributor behind Sysco and us Foods, with 9% market share. PFG's food-service business (52% of 2022 sales) provides customized food products and services (such as product selection and procurement) to independent and chain restaurants, and institutional customers. Acquisitions of Eby-Brown (2019) and Core-Mark (2021) enabled PFG to tap into the convenience store segment (41% of sales), offering convenience products, marketing programs, and technology solutions to convenience stores, drug stores, and other such channels. The firm's Vistar business (7% of sales) is a national distributor of candy, snacks, and beverages to vending and office coffee service distributors, theaters, and hospitality providers.